BPC-157 knee injections: retrospective phone survey of 16 clinic patients

Before you act: Don't stop, replace, or delay any treatment without talking to your doctor.

“This small study suggests that intra-articular injection of BPC-157 helps with multiple types of knee pain.”

Evidence level

Retrospective chart review with phone follow-up (16 patients), no control group, self-reported outcomes.

Funding

We could not access the full text to check its funding section; the study was done at the authors' own clinic (Institute for Hormonal Balance, Orlando).

What was published

A one-year chart review of patients given knee injections of BPC-157 alone or with thymosin beta-4 (TB4).

What it shows

"Of the 16 patients, 12 had received only BPC 157 ... 11 of the 12 patients (91.6%) had significant improvement in knee pain." "Overall, 14 of 16 patients (87.5%) had relief of their knee pain."

What it does not show

"No specific tools were used to measure their improvement in function, quality of life, stiffness or activities of daily living." Patients had different knee conditions and were asked to recall pain 6 months to a year later; without a control group, placebo effects and natural recovery can't be excluded.

Documented counterpoints

Reviewers note small sample, lack of control group and mixed diagnoses as major limitations; BPC-157 remains unapproved.

Source link

• Abstract (Europe PMC index; journal has no DOI)